Kolexia
Grimaldi-Bensouda Lamiae
Pharmacien
Hôpital Ambroise Paré
Boulogne-Billancourt, France
135 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} COVID-19 Accident vasculaire cérébral Infarctus du myocarde Infarctus Thrombopénie Fibrillation auriculaire Anévrysme Purpura thrombopénique idiopathique Anévrysme intracrânien

Industries

{{person.topindus1.name}}
{{person.topindus1.tot}} collaboration(s)
Dernière en {{person.topindus1.last}}
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

ESNV-SPA II: Randomized Cross Over Study Assessing the Effectiveness of Non-invasive Vagus Nerve Stimulation in Patients With Axial Spondyloarthritis Resistant to Biotherapies
Essai Clinique (Assistance publique – Hôpitaux de Paris)   30 janvier 2024
Exploring the impact of ursodeoxycholic acid therapy on COVID-19 in a real-word setting.
Journal of medical virology   22 janvier 2024
CLEVER: CLinical EValuation of WEB 0.017 Device in Intracranial AneuRysms
Essai Clinique (Terumo)   22 janvier 2024
Incidental diagnosis of lung cancer on chest CT scan performed for suspected or documented COVID-19 infection
Respiratory medicine and research   12 janvier 2024
CLinical EValuation of WEB 17 device in intracranial aneuRysms (CLEVER): procedural, 30-day and 1-year safety results for ruptured and unruptured aneurysms.
Journal of neurointerventional surgery   01 novembre 2023
COVID-19 Hospitalization in Solid Organ Transplant Recipients on Immunosuppressive Therapy.
JAMA network open   01 novembre 2023
Identification of factors associated with severe SARS-Cov-2 infection for patients treated with MS-specific disease-modifying therapies
Abstracts of ICPE 2023, the 39th international conference on pharmacoepidemiology and therapeutic risk management (ICPE), 25–27 August 2023, Halifax, Canada   12 octobre 2023
Protective effects of medications on cardiovascular events in systemic lupus erythematosus in real-life: A systematic new-user cohort study
Abstracts of ICPE 2023, the 39th international conference on pharmacoepidemiology and therapeutic risk management (ICPE), 25–27 August 2023, Halifax, Canada   12 octobre 2023
Aspirin and non-aspirin antiplatelet agents use and risk of ischemic and hemorrhagic stroke in patients with non-valvular atrial fibrillation with and without anticoagulant therapy: A case-referent study
Abstracts of ICPE 2023, the 39th international conference on pharmacoepidemiology and therapeutic risk management (ICPE), 25–27 August 2023, Halifax, Canada   12 octobre 2023
Immunosuppressive therapy and COVID-19-related hospitalization in solid organ transplant recipients: A French nationwide cohort study
Abstracts of ICPE 2023, the 39th international conference on pharmacoepidemiology and therapeutic risk management (ICPE), 25–27 August 2023, Halifax, Canada   12 octobre 2023